Ticker > Company >

Fermenta Biotech share price

Fermenta Biotech Ltd.

BSE: 506414 SECTOR: Pharmaceuticals & Drugs  23.74 K   66   10

320.00
+2.45 (0.77%)
BSE: 29 Aug 04:01 PM

Price Summary

Today's High

₹ 330

Today's Low

₹ 315.15

52 Week High

₹ 449

52 Week Low

₹ 219

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

941.79 Cr.

Enterprise Value

989.24 Cr.

No. of Shares

2.94 Cr.

P/E

10.62

P/B

2.38

Face Value

₹ 5

Div. Yield

0.79 %

Book Value (TTM)

₹  134.56

CASH

61.95 Cr.

DEBT

109.4 Cr.

Promoter Holding

64.09 %

EPS (TTM)

₹  30.14

Sales Growth

40.2%

ROE

19.85 %

ROCE

19.07%

Profit Growth

460.74 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year40.2%
3 Year3.53%
5 Year7.46%

Profit Growth

1 Year460.74%
3 Year30.77%
5 Year1.21%

ROE%

1 Year19.85%
3 Year-0.78%
5 Year4.29%

ROCE %

1 Year19.07%
3 Year5.15%
5 Year7.97%

Debt/Equity

0.2882

Price to Cash Flow

27.84

Interest Cover Ratio

6.0154

CFO/PAT (5 Yr. Avg.)

5.07549811204095

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 64.09 0.00
Mar 2025 64.09 0.00
Dec 2024 62.06 0.00
Sep 2024 62.06 0.00
Jun 2024 62.06 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 30.7678161310373% for the Past 3 years.
  • Company’s PEG ratio is 0.0232279746662525.
  • The company has an efficient Cash Conversion Cycle of 2.58610000000002 days.
  • The company has a good cash flow management; CFO/PAT stands at 5.07549811204095.
  • The company has a high promoter holding of 64.09%.

 Limitations

  • The company has shown a poor revenue growth of 3.53146350517188% for the Past 3 years.
  • Company has a poor ROE of -0.781066666666666% over the past 3 years.
  • Tax rate is low at 9.144.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 72.7 89.54 146.25 122.04 119.02
Total Expenditure 70.89 74.05 96.12 89.36 96.49
Operating Profit 1.81 15.49 50.14 32.67 22.53
Other Income 2.63 2.95 2.22 3.88 8.84
Interest 3.42 3.69 4.09 2.99 3.11
Depreciation 5.87 5.89 5.82 5.6 5.55
Exceptional Items 0 0 0 0 0
Profit Before Tax -4.85 8.86 42.45 27.97 22.72
Tax 0 0.7 7.45 -1.34 6.49
Profit After Tax -4.85 8.16 35 29.31 16.24
Adjusted EPS (Rs) -1.68 2.81 12 10.05 5.57

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 372.82 387.96 328.91 307.09 430.53
Total Expenditure 278.2 311.25 289.93 269.76 330.76
Operating Profit 94.63 76.71 38.99 37.33 99.77
Other Income 6.73 7.63 8.46 8.15 12.66
Interest 19.1 18.11 21.35 17.4 14.84
Depreciation 19.03 23.67 24.48 23.7 23.17
Exceptional Items 0 0 -59.59 -9 0
Profit Before Tax 63.23 42.56 -57.98 -4.61 74.42
Tax 11.26 12.33 -0.97 14.14 6.81
Net Profit 51.97 30.24 -57 -18.74 67.62
Adjusted EPS (Rs.) 18.02 10.48 -19.75 -6.49 23.18

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 14.42 14.42 14.43 14.44 14.58
Total Reserves 356.02 381.55 321.63 299.79 365.37
Borrowings 110.44 114.68 83.54 42.59 15.05
Other N/C liabilities 24.87 43.72 13.8 34.49 14.2
Current liabilities 213.58 207.38 233.34 181.7 231.75
Total Liabilities 719.33 761.76 666.74 573.01 640.94
Assets
Net Block 249.57 219.98 228.11 261.4 222.65
Capital WIP 52.7 29.89 41.9 1.62 15.91
Intangible WIP 4.21 4.67 3.12 0 0
Investments 12.95 12.99 12.57 3.63 3.69
Loans & Advances 70.36 87.66 54.28 39.85 39.58
Other N/C Assets 0.86 70.6 52.72 7.47 5.28
Current Assets 328.69 335.97 274.04 259.04 353.84
Total Assets 719.33 761.76 666.74 573.01 640.94
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 63.23 42.56 -57.98 -4.61 74.42
Adjustment 40.23 38.95 146.85 85.43 40.32
Changes in Assets & Liabilities -27.01 -21.83 30.53 23.18 -78.14
Tax Paid -13.49 -9.28 4.35 1.02 -2.77
Operating Cash Flow 62.96 50.41 123.75 105.02 33.83
Investing Cash Flow -43.61 -32.46 -63.47 -15.15 0.41
Financing Cash Flow -1.32 -21.76 -41.25 -90.86 -50.91
Net Cash Flow 18.03 -3.81 19.03 -0.98 -16.67

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 62.06 62.06 62.06 64.09 64.09
anupama datla desai 8.70 8.70 8.70 8.70 8.70
krishna datla 34.01 34.01 34.01 36.04 36.04
preeti thakkar 7.61 7.61 7.61 7.61 7.61
satish varma azad nadimpa... 11.73 11.73 11.73 11.73 11.73
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 37.94 37.94 37.94 35.91 35.91
hima pathak . - - - 1.02 1.02
investor education and pr... 0.54 0.54 - - 0.59
krishan premnarayen . - - - 1.38 1.38
llp 0.06 0.08 0.11 0.11 0.07
rakesh kantilal shah 3.47 2.10 2.04 2.04 1.77
investor education and pr... - - 0.59 0.59 -
krishan premnarayen 1.38 1.38 1.38 - -
kunal ashok kashyap 2.08 1.63 1.59 - -
rajeshwari datla 2.02 2.02 2.02 - -
fermenta biotech limited ... - 1.47 - - -
shri patan jain mandal - 1.11 - - -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CARE
Credit CARE
Credit CARE
Credit CARE
Credit CARE
Credit CARE
Credit CARE
Credit CARE
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
Research BP Wealth

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY21
Concall Q3FY22
Concall Q3FY21
Concall Q2FY22
Concall Q2FY21
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY23
Presentation Q4FY23
Presentation Q4FY22
Presentation Q4FY22
Presentation Q4FY22
Presentation Q4FY22
Presentation Q4FY21
Presentation Q4FY20
Presentation Q3FY24
Presentation Q3FY22
Presentation Q3FY22
Presentation Q3FY22
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY24
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY25
Presentation Q1FY24
Presentation Q1FY23
Presentation Q1FY22
Presentation Q1FY21

Company News

Fermenta Biotech - Quaterly Results 12 Aug, 1:06 PM Fermenta Biotech - Quaterly Results 12 Aug, 1:06 PM Fermenta Biotech - Quaterly Results 12 Aug, 1:06 PM Fermenta Biotech secures CEP from EDQM for Vitadee 100 SD 30 Jul, 11:42 AM Fermenta Biotech informs about certificate 21 Jul, 3:15 PM Fermenta Biotech enters into strategic MoU with NIFTEM-T 11 Jul, 6:01 PM Fermenta Biotech - Quaterly Results 28 May, 3:49 PM Fermenta Biotech - Quaterly Results 28 May, 3:49 PM Fermenta Biotech informs about non-applicability of large corporate entity 29 Apr, 11:53 AM Fermenta Biotech informs about disclosure 17 Apr, 5:31 PM Fermenta Biotech informs about newspaper publication 12 Feb, 4:20 PM Fermenta Biotech - Quaterly Results 11 Feb, 2:12 PM Fermenta Biotech - Quaterly Results 11 Feb, 2:12 PM Fermenta Biotech - Quaterly Results 11 Feb, 2:12 PM Fermenta Biotech informs about closure of trading window 31 Dec, 2:18 PM Fermenta Biotech informs about loss of share certificate 21 Aug, 12:53 PM Fermenta Biotech - Quaterly Results 12 Aug, 2:05 PM Fermenta Biotech - Quaterly Results 12 Aug, 2:05 PM Fermenta Biotech - Quaterly Results 12 Aug, 2:05 PM Fermenta Biotech informs about change in management 24 Jul, 12:34 PM Fermenta Biotech gets EIR for Gujarat manufacturing facility 6 Jul, 10:40 AM Fermenta Biotech informs about successful closure of inspection 6 Jul, 9:41 AM Fermenta Biotech - Quaterly Results 27 May, 4:14 PM Fermenta Biotech - Quaterly Results 27 May, 4:14 PM Fermenta Biotech - Quaterly Results 27 May, 4:14 PM Fermenta Biotech submits intimation about retirement of directors 2 Apr, 5:03 PM Fermenta Biotech informs about change in independent director 23 Mar, 2:46 PM Fermenta Biotech informs about loss of share certificates 26 Feb, 3:24 PM Fermenta Biotech - Quaterly Results 12 Feb, 1:38 PM Fermenta Biotech - Quaterly Results 12 Feb, 1:38 PM Fermenta Biotech - Quaterly Results 12 Feb, 1:38 PM Fermenta Biotech informs about loss of share certificate 8 Jan, 1:43 PM Fermenta Biotech informs about loss of share certificate 7 Dec, 1:11 PM Fermenta Biotech executes sale deed to sell land in Pune 4 Dec, 5:10 PM Fermenta Biotech - Quaterly Results 8 Nov, 1:46 PM Fermenta Biotech informs about details of loss of certificate 1 Nov, 12:56 PM Fermenta Biotech informs about updates 7 Sep, 5:13 PM Fermenta Biotech inaugurates premix plant in Himachal Pradesh 7 Sep, 4:12 PM Fermenta Biotech informs about details of loss of certificate 23 Aug, 12:47 PM Fermenta Biotech - Quaterly Results 11 Aug, 1:39 PM Fermenta Biotech - Quaterly Results 11 Aug, 1:39 PM Fermenta Biotech informs about details of loss of certificate 9 Aug, 1:04 PM Fermenta Biotech informs about closure of trading window 30 Jun, 4:35 PM Fermenta Biotech informs about compliance report 30 May, 3:23 PM Fermenta Biotech informs about loss of share certificates 18 May, 4:12 PM Fermenta Biotech executes sale deed to sell premises in Thane 17 May, 3:51 PM Fermenta Biotech executes sale deed to sell premises at Thane 16 May, 10:00 AM Fermenta Biotech informs about compliance certificate 17 Apr, 11:52 AM Fermenta Biotech informs about loss of share certificates 11 Apr, 12:28 PM Fermenta Biotech executes sale deed to sell premises in Thane 28 Mar, 4:06 PM

Fermenta Biotech Stock Price Analysis and Quick Research Report. Is Fermenta Biotech an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Fermenta Biotech. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Fermenta Biotech has a PE ratio of 10.617472377982 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Fermenta Biotech has ROA of 11.1397% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Fermenta Biotech has a Current ratio of 1.5268.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Fermenta Biotech has a ROE of 19.8535%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Fermenta Biotech has a Debt to Equity ratio of 0.2882 which means that the company has low proportion of debt in its capital.

  • Sales growth: Fermenta Biotech has reported revenue growth of 40.1971% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Fermenta Biotech for the current financial year is 23.1742749720868%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Fermenta Biotech is Rs 2.5 and the yield is 0.7873%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Fermenta Biotech is Rs 30.139. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Fermenta Biotech in Ticker for free. Also, one can get the intrinsic value of Fermenta Biotech by using Valuation Calculators, which are available with a Finology ONE subscription. 

Fermenta Biotech FAQs

Q1. What is Fermenta Biotech share price today?
Ans: The current share price of Fermenta Biotech is Rs 320.

Q2. What is the market capitalisation of Fermenta Biotech?
Ans: Fermenta Biotech has a market capitalisation of Rs 941.791584 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Fermenta Biotech?
Ans: The PE ratio of Fermenta Biotech is 10.617472377982 and the P/B ratio of Fermenta Biotech is 2.3781513292008, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Fermenta Biotech share?
Ans: The 52-week high share price of Fermenta Biotech is Rs 449, and the 52-week low share price of Fermenta Biotech is Rs 219.

Q5. Does Fermenta Biotech pay dividends?
Ans: Currently, Fermenta Biotech pays dividends. Dividend yield of Fermenta Biotech is around 0.7873%.

Q6. What are the face value and book value of Fermenta Biotech shares?
Ans: The face value of Fermenta Biotech shares is Rs 5, while the book value per share of Fermenta Biotech is around Rs 134.5583. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Fermenta Biotech?
Ans: Fermenta Biotech has a total debt of Rs 109.4004 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Fermenta Biotech?
Ans: The ROE of Fermenta Biotech is 19.8535% and ROCE of Fermenta Biotech is 19.0743%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Fermenta Biotech a good buy for the long term?
Ans: The Fermenta Biotech long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Fermenta Biotech undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Fermenta Biotech appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Fermenta Biotech’s financials?
Ans: You can review Fermenta Biotech’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Fermenta Biotech
X